Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Zynex, Inc. (ZYXI)

8.07   0.09 (1.13%) 07-02 19:52
Open: 7.94 Pre. Close: 7.98
High: 8.2 Low: 7.76
Volume: 209,691 Market Cap: 311(M)
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 8.21 - 8.24 8.24 - 8.28
Low: 7.68 - 7.71 7.71 - 7.75
Close: 8.01 - 8.06 8.06 - 8.12

Technical analysis

as of: 2022-07-01 4:26:28 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 10.78     One year: 12.59
Support: Support1: 7.57    Support2: 6.55
Resistance: Resistance1: 9.22    Resistance2: 10.78
Pivot: 7.81
Moving Average: MA(5): 8     MA(20): 7.76
MA(100): 6.78     MA(250): 9.43
MACD: MACD(12,26): 0.2     Signal(9): 0.2
Stochastic oscillator: %K(14,3): 51.9     %D(3): 51.6
RSI: RSI(14): 55.3
52-week: High: 16.26  Low: 4.96
Average Vol(K): 3-Month: 492 (K)  10-Days: 602 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ZYXI ] has closed below upper band by 34.0%. Bollinger Bands are 2.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 30 Jun 2022
Where Does Zynex Inc. (ZYXI) Stock Fall in the Medical Distribution Field? - InvestorsObserver

Wed, 29 Jun 2022
Nordea Investment Management AB Increases Stock Position in Zynex, Inc. (NASDAQ:ZYXI) - Defense World

Fri, 24 Jun 2022
Should Zynex Inc. (ZYXI) Stock Be in Your Portfolio? - InvestorsObserver

Wed, 22 Jun 2022
Healthcare Stocks Making Moves Wednesday: OMER, BTTX, XXII, VOR, ATHA, NEPT, ZYXI, GRAMF - InvestorsObserver

Thu, 09 Jun 2022
Zynex announces additional $10M buyback - Seeking Alpha

Thu, 09 Jun 2022
Health Care Sector Update for 06/09/2022: XLV, ZYXI, SONN, IGC - Nasdaq

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Distribution
Shares Out. 40 (M)
Shares Float 23 (M)
% Held by Insiders 42.5 (%)
% Held by Institutions 35.3 (%)
Shares Short 5,650 (K)
Shares Short P.Month 5,600 (K)

Stock Financials

EPS 0.25
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 1.63
Profit Margin (%) 13.9
Operating Margin (%) 18.4
Return on Assets (ttm) 15.6
Return on Equity (ttm) 29
Qtrly Rev. Growth 28.7
Gross Profit (p.s.) 2.57
Sales Per Share 3.42
EBITDA (p.s.) 0.69
Qtrly Earnings Growth 0
Operating Cash Flow 14 (M)
Levered Free Cash Flow 11 (M)

Stock Valuations

PE Ratio 32.27
PEG Ratio 0
Price to Book value 4.92
Price to Sales 2.35
Price to Cash Flow 23.09

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2022-01-20
Ex-Dividend Date 2022-01-04
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.